Jacobs Levy Equity Management, Inc Laboratory Corp Of America Holdings Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$113.31 - $182.44 $543,094 - $874,434	-4,793 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $203,319 - $380,600	-1,949 Reduced 28.91%	4,793 $606,000
Q4 2019 Feb 14, 2020	SELL	$163.48 - $173.61 $1.48 Million - $1.57 Million	-9,038 Reduced 57.28%	6,742 $1.14 Million
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $1.35 Million - $1.5 Million	8,440 Added 114.99%	15,780 $2.65 Million
Q2 2019 Aug 13, 2019	BUY	$144.16 - $172.9 $1.06 Million - $1.27 Million	7,340 New	7,340 $1.27 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.